Quantum-Si (NASDAQ:QSI) Releases Earnings Results, Beats Expectations By $0.06 EPS

Quantum-Si (NASDAQ:QSI) released its quarterly earnings results on Tuesday. The company reported ($0.08) EPS for the quarter, topping analysts’ consensus estimates of ($0.14) by $0.06, FiscalAI reports. Quantum-Si had a negative return on equity of 47.90% and a negative net margin of 3,677.97%.The company had revenue of $0.45 million for the quarter, compared to analyst estimates of $0.76 million.

Quantum-Si Stock Up 1.6%

Shares of NASDAQ:QSI traded up $0.01 during midday trading on Tuesday, reaching $0.95. The company had a trading volume of 3,043,075 shares, compared to its average volume of 4,449,540. The stock has a market cap of $204.28 million, a PE ratio of -1.41 and a beta of 2.98. Quantum-Si has a 1-year low of $0.89 and a 1-year high of $3.10. The business’s 50 day moving average price is $1.13 and its 200 day moving average price is $1.38.

Insiders Place Their Bets

In other news, insider John S. Vieceli sold 21,927 shares of the company’s stock in a transaction dated Monday, December 22nd. The shares were sold at an average price of $1.28, for a total value of $28,066.56. Following the sale, the insider directly owned 800,973 shares of the company’s stock, valued at approximately $1,025,245.44. This represents a 2.66% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, CEO Jeffrey Alan Hawkins sold 23,707 shares of the firm’s stock in a transaction that occurred on Monday, December 22nd. The shares were sold at an average price of $1.28, for a total value of $30,344.96. Following the completion of the sale, the chief executive officer directly owned 2,578,018 shares of the company’s stock, valued at approximately $3,299,863.04. The trade was a 0.91% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. In the last quarter, insiders sold 54,261 shares of company stock valued at $69,454. Corporate insiders own 30.04% of the company’s stock.

Institutional Inflows and Outflows

Several large investors have recently added to or reduced their stakes in the company. Shay Capital LLC boosted its holdings in Quantum-Si by 19.2% in the 3rd quarter. Shay Capital LLC now owns 154,572 shares of the company’s stock valued at $218,000 after purchasing an additional 24,941 shares during the period. Wells Fargo & Company MN raised its position in shares of Quantum-Si by 29.6% in the 4th quarter. Wells Fargo & Company MN now owns 176,132 shares of the company’s stock valued at $194,000 after buying an additional 40,182 shares in the last quarter. JPMorgan Chase & Co. lifted its holdings in shares of Quantum-Si by 15.6% during the 2nd quarter. JPMorgan Chase & Co. now owns 66,656 shares of the company’s stock worth $131,000 after acquiring an additional 9,005 shares during the period. Invesco Ltd. boosted its position in shares of Quantum-Si by 177.7% during the 1st quarter. Invesco Ltd. now owns 103,657 shares of the company’s stock worth $124,000 after acquiring an additional 66,336 shares in the last quarter. Finally, HRT Financial LP bought a new position in Quantum-Si in the fourth quarter valued at approximately $114,000. Institutional investors own 39.90% of the company’s stock.

Analyst Upgrades and Downgrades

A number of brokerages have weighed in on QSI. Canaccord Genuity Group cut their price target on shares of Quantum-Si from $2.00 to $1.50 and set a “hold” rating on the stock in a research note on Monday, December 22nd. Weiss Ratings restated a “sell (d-)” rating on shares of Quantum-Si in a report on Monday, December 29th. Two investment analysts have rated the stock with a Buy rating, one has assigned a Hold rating and one has assigned a Sell rating to the stock. According to data from MarketBeat.com, Quantum-Si presently has an average rating of “Hold” and a consensus target price of $3.55.

About Quantum-Si

Quantum-Si Inc is a life sciences instrumentation company headquartered in Guilford, Connecticut, developing next-generation proteomics solutions based on semiconductor sequencing technology. The company’s core offering centers on a proprietary single-molecule protein sequencing platform that uses a silicon-based sensor chip to convert protein data into digital signals. This approach is designed to deliver high sensitivity, single-amino-acid resolution and deep proteome coverage while potentially reducing cost and complexity compared to traditional mass spectrometry methods.

Quantum-Si’s product roadmap includes the development and commercialization of an integrated system comprising instruments, consumable reagents and proprietary data analysis software.